These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 20170166)
1. Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. Rauser S; Marquardt C; Balluff B; Deininger SO; Albers C; Belau E; Hartmer R; Suckau D; Specht K; Ebert MP; Schmitt M; Aubele M; Höfler H; Walch A J Proteome Res; 2010 Apr; 9(4):1854-63. PubMed ID: 20170166 [TBL] [Abstract][Full Text] [Related]
2. Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier. Balluff B; Elsner M; Kowarsch A; Rauser S; Meding S; Schuhmacher C; Feith M; Herrmann K; Röcken C; Schmid RM; Höfler H; Walch A; Ebert MP J Proteome Res; 2010 Dec; 9(12):6317-22. PubMed ID: 21058730 [TBL] [Abstract][Full Text] [Related]
3. Protein identification by accurate mass matrix-assisted laser desorption/ionization imaging of tryptic peptides. Schober Y; Schramm T; Spengler B; Römpp A Rapid Commun Mass Spectrom; 2011 Sep; 25(17):2475-83. PubMed ID: 21818808 [TBL] [Abstract][Full Text] [Related]
4. Direct identification of proteins from T47D cells and murine brain tissue by matrix-assisted laser desorption/ionization post-source decay/collision-induced dissociation. Pevsner PH; Naftolin F; Hillman DE; Miller DC; Fadiel A; Kogus A; Stern A; Samuels HH Rapid Commun Mass Spectrom; 2007; 21(3):429-36. PubMed ID: 17216666 [TBL] [Abstract][Full Text] [Related]
5. MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78 kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections. Djidja MC; Claude E; Snel MF; Scriven P; Francese S; Carolan V; Clench MR J Proteome Res; 2009 Oct; 8(10):4876-84. PubMed ID: 19673544 [TBL] [Abstract][Full Text] [Related]
6. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections. Djidja MC; Francese S; Loadman PM; Sutton CW; Scriven P; Claude E; Snel MF; Franck J; Salzet M; Clench MR Proteomics; 2009 May; 9(10):2750-63. PubMed ID: 19405023 [TBL] [Abstract][Full Text] [Related]
7. Discovery and verification of protein differences between Er positive/Her2/neu negative breast tumor tissue and matched adjacent normal breast tissue. Weitzel LR; Byers T; Allen J; Finlayson C; Helmke SM; Hokanson JE; Hunsucker SW; Murphy JR; Newell K; Queensland KM; Singh M; Wischmeyer PE; Duncan MW; Elias A Breast Cancer Res Treat; 2010 Nov; 124(2):297-305. PubMed ID: 20087651 [TBL] [Abstract][Full Text] [Related]
8. In situ identification and localization of IGHA2 in the breast tumor microenvironment by mass spectrometry. Kang S; Maeng H; Kim BG; Qing GM; Choi YP; Kim HY; Kim PS; Kim Y; Kim YH; Choi YD; Cho NH J Proteome Res; 2012 Sep; 11(9):4567-74. PubMed ID: 22894699 [TBL] [Abstract][Full Text] [Related]
10. On the importance of mathematical methods for analysis of MALDI-imaging mass spectrometry data. Trede D; Kobarg JH; Oetjen J; Thiele H; Maass P; Alexandrov T J Integr Bioinform; 2012 Mar; 9(1):189. PubMed ID: 22433312 [TBL] [Abstract][Full Text] [Related]
11. Protein- versus peptide fractionation in the first dimension of two-dimensional high-performance liquid chromatography-matrix-assisted laser desorption/ionization tandem mass spectrometry for qualitative proteome analysis of tissue samples. Melchior K; Tholey A; Heisel S; Keller A; Lenhof HP; Meese E; Huber CG J Chromatogr A; 2010 Oct; 1217(40):6159-68. PubMed ID: 20810122 [TBL] [Abstract][Full Text] [Related]
12. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker. Lemaire R; Menguellet SA; Stauber J; Marchaudon V; Lucot JP; Collinet P; Farine MO; Vinatier D; Day R; Ducoroy P; Salzet M; Fournier I J Proteome Res; 2007 Nov; 6(11):4127-34. PubMed ID: 17939699 [TBL] [Abstract][Full Text] [Related]
14. Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma. Dekker TJ; Balluff BD; Jones EA; Schöne CD; Schmitt M; Aubele M; Kroep JR; Smit VT; Tollenaar RA; Mesker WE; Walch A; McDonnell LA J Proteome Res; 2014 Nov; 13(11):4730-8. PubMed ID: 24762205 [TBL] [Abstract][Full Text] [Related]
15. Use of serological proteomic methods to find biomarkers associated with breast cancer. Rui Z; Jian-Guo J; Yuan-Peng T; Hai P; Bing-Gen R Proteomics; 2003 Apr; 3(4):433-9. PubMed ID: 12687611 [TBL] [Abstract][Full Text] [Related]
16. Molecular proteomics imaging of tumor interfaces by mass spectrometry. Kang S; Shim HS; Lee JS; Kim DS; Kim HY; Hong SH; Kim PS; Yoon JH; Cho NH J Proteome Res; 2010 Feb; 9(2):1157-64. PubMed ID: 19821573 [TBL] [Abstract][Full Text] [Related]
17. Combination of immunohistochemistry and laser ablation ICP mass spectrometry for imaging of cancer biomarkers. Seuma J; Bunch J; Cox A; McLeod C; Bell J; Murray C Proteomics; 2008 Sep; 8(18):3775-84. PubMed ID: 18712769 [TBL] [Abstract][Full Text] [Related]
18. Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics. Fagerquist CK; Garbus BR; Miller WG; Williams KE; Yee E; Bates AH; Boyle S; Harden LA; Cooley MB; Mandrell RE Anal Chem; 2010 Apr; 82(7):2717-25. PubMed ID: 20232878 [TBL] [Abstract][Full Text] [Related]
19. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732 [TBL] [Abstract][Full Text] [Related]
20. MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. Deininger SO; Ebert MP; Fütterer A; Gerhard M; Röcken C J Proteome Res; 2008 Dec; 7(12):5230-6. PubMed ID: 19367705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]